Earnings in Focus: P10, Zymeworks, Gevo, and WalkMe Gear Up
- August 06th, 2023
- 473 views
A lineup of companies is gearing up to unveil their financial performance on Thursday, August 10, providing valuable insights into their recent activities and market dynamics, including:
P10, Inc. (NYSE: PX), a versatile company, is scheduled to release its second-quarter 2023 results following the close of U.S. markets.
Analysts' consensus points to an anticipated EPS of $0.18 on revenue totaling $57.13 million.
$PX closed at $11.83 on Friday, up $0.24 (+2.07%).
Zymeworks Inc. (Nasdaq: ZYME), a notable player in the biotechnology sector, will be reporting its second-quarter 2023 financial results after the market closes.
Market analysts are expecting a loss of $0.47 per share on revenue amounting to $12.36 million.
On Friday, $ZYME closed at $7.39, reflecting a gain of $0.07 (+0.96%).
Gevo, Inc. (Nasdaq: GEVO), a company focused on sustainable solutions, is set to reveal its financial results for the second quarter of 2023 following the close of the market.
The consensus estimate points to a loss of $0.05 per share on revenue totaling $4 million.
$GEVO closed at $1.57 on Friday, down $0.02 (-1.25%).
WalkMe Ltd. (Nasdaq: WKME), a leader in digital adoption, will release its second-quarter 2023 financial results before the opening of U.S. markets.
Analysts are forecasting a loss of $0.07 per share with revenue projected to reach $65.7 million.
On Friday, $WKME closed at $8.73, marking an increase of $0.08 (+0.92%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login